nicergoline has been researched along with gamma-aminobutyric acid in 1 studies
*gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system. [MeSH]
*gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Battaglia, A; Calzà, L; Fernandez, M; Giardino, L; Pignataro, O; Zanni, M | 1 |
1 other study(ies) available for nicergoline and gamma-aminobutyric acid
| Article | Year |
|---|---|
Plasticity of GABA(a) system during ageing: focus on vestibular compensation and possible pharmacological intervention.
Topics: Adaptation, Physiological; Aging; Animals; Brain; Flunitrazepam; GABA Modulators; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Male; Neuronal Plasticity; Nicergoline; Nootropic Agents; Postural Balance; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Recovery of Function; RNA, Messenger; Synaptic Transmission; Vestibular Diseases; Vestibule, Labyrinth | 2002 |